Search
IRadimed Corp
IRMDAdd to Watchlist
99.463USD
+1.423+1.45%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.27BMarket Cap
53.66P/E TTM
More Details of IRadimed Corp Company
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
IRadimed Corp Info
Ticker SymbolIRMD
Company nameIRadimed Corp
IPO dateJul 16, 2014
CEOSusi (Roger)
Number of employees160
Security typeOrdinary Share
Fiscal year-endJul 16
Address12705 Ingenuity Drive
CityORLANDO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32826
Phone14076778022
Websitehttps://www.iradimed.com/
Ticker SymbolIRMD
IPO dateJul 16, 2014
CEOSusi (Roger)
Company Executives of IRadimed Corp
Name
Name/Position
Position
Shareholding
Change
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Joe Kiani
Mr. Joe Kiani
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of IRadimed Corp?
The top five shareholders of IRadimed Corp are: Mr. James B. (Jim) Hawkins
How many institutions hold shares of IRadimed Corp (IRMD)?
As of 2026Q1, 407 institutions hold shares of IRadimed Corp, with a combined market value of approximately 8.32M, accounting for 65.08% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -453182.00.
What is the biggest source of revenue for IRadimed Corp?
In 2026Q1, the MRI Compatible IV Infusion Pump Systems business generated the highest revenue for IRadimed Corp, amounting to 31.64M and accounting for 37.75% of total revenue.